Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $2.61 | Change: $-0.09 | %Change: -3.33%
Volume: 5,625 | Day High/Low: 2.66/2.61 | 52 Week High/Low: 5.73/1.35


View modes: 
5 stars

RE:rtq

$3.15 & about 15,500 shares traded on the TSX as of 2:53  rate and reply
0 stars

rtq

could someone please provide a real time quote and vollume? thank you  rate and reply
3 stars

RE:RE:RE:Take a look at the amount of reads...Lots of followers here

Hey, if you post talked about the chart or talked about what people are speculating about I wouldn't have had a problem with it. I've been on board for ages -- but I still believe management will...read more
3 stars

RE:RE:Take a look at the amount of reads...Lots of followers here

Am I? Are you sure about that? The price is up again this morning and continues to go up! By the time you get on board at these lower prices, you will have to pay much more, it's as simple as that...read more
4 stars

Take a look at the amount of reads...Lots of followers here

Just look at the amount of reads these posts are getting on this Nuvo Bullboard site for the posts that are written! That tells me that there are a lot of people on the sidelines here that follow and...read more
2 stars

off topic

seen recently - Investor Poll: Over the next 60 days, do you expect marijuana related stocks to  get higher?  rate and reply
4.5 stars

RE:RE:RE:RE:RE:IMHO you're all missing the point.

This is a very rough calculation.                                                                  pre-consolidation    post-consolidation 65:1 shares:                                                ...read more
5 stars

RE:RE:RE:RE:IMHO you're all missing the point.

Thanks.What % of stock is held by the pirates/institutions/retail? Unless the pirates hold a botload of stock which I doubt, my take is an unwanted buy out would be difficult to stop.  Also, how many...read more
4.5 stars

RE:RE:RE:IMHO you're all missing the point.

many moons ago under the Keeler regime, there was a poison pill where the number of shares doubled and it made it difficult for an unwanted takeover. I don't know if this still exists today. Keep in...read more
4 stars

RE:RE:IMHO you're all missing the point.

Does anyone know if there is a poison pill in place by the leeches here?  rate and reply
3 stars

RE:Novo ranked in top 10 performers in 2014

rock07, As a Pirate friend/family member, you have NO right to post here.  Top performer???  Your papa almost bankrupted the company last year, thank you very much.  $2.15 is ONLY  3.3 CENTS pre...read more
4.5 stars

RE:RE:Take-over of NRI is imminent in my opinion...

Ronz, you brought up some very interesting points about who Goodman and Co.  In my opinion, Goodman (through Palladin and Knight) seem to be far too close (with possible side deals, or wink winks...read more
4.5 stars

RE:Take-over of NRI is imminent in my opinion...

Looking objectively at Nuvo's assets the biggest upside left is WF10 and a possible settlement of the lawsuit. I realize Nuvo has four FDA approved drugs BUT these are already under marketing...read more
3.5 stars

Take-over of NRI is imminent in my opinion...

Call it just a hunch, but with the consolidation going on in the sector, and certain companies with cash in hand looking to grab FDA approved drugs or late stage product potential that have marketing...read more
2.5 stars

Novo ranked in top 10 performers in 2014

10. Nuvo Research (TSX:NRI) +41.8% Closing Price December 31st, 2013: $2.15 Closing Price February 18th, 2014: $3.05 Shares of Nuvo Research caught fire early in January and haven’t looked back....read more
5 stars

I wonder why....

I wonder why there's no announcement about 2M Nuvo is entitle to receive following the approval of Pliaglis in Brazil....... probably Galderma delay the laungh of Pliaglis ...... and than no money for...read more
3 stars

there are games being played with the trading

watching this for the past couple weeks, the bids and asks are being shifted around constantly with clearly no intent to actually transact.  It's being boxed to ensure it stays  around the $3.00 level...read more
5 stars

RE:RE:RE:RE:RE:RE:RE:Investor Presentation

Positive "sounding" news is used to bouy the stock if possible and then it's dilution time baby. Of course, management finds ways to "earn" the rewards needed to stay afloat and probably even boost...read more
1 star

RE:RE:RE:RE:RE:RE:Investor Presentation

The AGM is is also a special AGM. Knights takeout offer will be the first agenda item. Be aboard. Ignore the little folk.  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:Investor Presentation

error corrected - paddypower wrote: July 2013, News Release on drawing down $4million more from Paladin's (15% eh?) loan: Nuvos Vice Presiden/Chief financial officer said:                            ...read more